Clinical Trial Update: Phase II Study of T-DX in HER2-positive Breast Cancer Brain Metastases [Phase 2]

View source ↗

Summary

Phase II study update for T-DX in HER2-positive breast cancer with brain metastases has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• T-DX

Snippet

Sponsor: Medical University of Vienna | Conditions: Breast Cancer Stage IV | Phase 2 | Status: COMPLETED